The Medicare Advantage Cost Transparency Act requires Medicare Advantage insurance plans to include additional financial and service information when they submit encounter data to the federal government starting January 1, 2027. Specifically, plans must report the allowed amounts charged for medical items and services, the cost-sharing amounts patients pay such as copayments and deductibles, and whether patients received in-home health risk assessments from affiliated or non-affiliated assessment companies. This bill affects Medicare Advantage plans and their enrollees by increasing transparency around costs and health assessments. The legislation does not establish new funding but instead imposes new data reporting requirements on existing Medicare Advantage plans. The changes take effect for plan years beginning on or after January 1, 2027.

This resolution expresses the House of Representatives' support for policies that allow broad access to mifepristone, a medication used for abortion and miscarriage management. The resolution states that over 25 years of scientific evidence and hundreds of peer-reviewed studies demonstrate the drug is safe and effective, and argues that policies governing access to mifepristone should be based on this scientific evidence rather than political considerations. The resolution supports allowing mifepristone to be prescribed through telemedicine and dispensed by mail or at pharmacies, and emphasizes that current restrictions on the drug are more stringent than those applied to 99 percent of other prescription medications. The resolution also argues that expanding access to medication abortion is necessary to ensure equitable care for marginalized communities, including Black and Indigenous people, immigrants, people with lower incomes, rural residents, and LGBTQ+ individuals. As a sense-of-the-House resolution, this measure expresses the legislative body's position but does not enact new law or allocate funding.

This bill strengthens the Food and Drug Administration's authority and resources to regulate human foods and support food safety research. It establishes a permanent Advisory Committee on Human Foods to advise the FDA on food science, nutrition, and safety issues, and creates a competitive grant program for critical research in areas like food biotechnology, infant nutrition, ultra-processed foods, and dietary supplements. The legislation also establishes a center of excellence to improve nutrition science and coordinate programs between the FDA's Human Foods Program and drug evaluation center, particularly addressing emerging areas like weight-loss medications and medical food interventions. Additionally, the bill requires processed food manufacturers to maintain detailed records of recipes and ingredients, including unlabeled contents like flavors and additives that the FDA can access and publish. The bill also exempts FDA research from certain federal paperwork reduction requirements and directs the FDA to partner with outside organizations to share information about food packaging materials and recommend chemical limits in foods, with annual reporting to Congress. While the legislation does not specify a total funding amount, it directs Congress to consider establishing a "Human Foods Innovation Account" to support these various FDA activities and food sector modernization efforts.

The Colorado Wilderness Act of 2026 designates approximately 600,000 acres of Colorado public lands as new wilderness areas within the National Wilderness Preservation System, creating 33 new wilderness areas and expanding 5 existing ones primarily from Bureau of Land Management and U.S. Forest Service lands across western and central Colorado. The bill also designates three "potential wilderness" areas that will become full wilderness once existing military and other authorized uses cease. Management provisions allow military helicopter overflights and training exercises to continue, permit competitive running events in specific areas, and establish that activities outside wilderness boundaries cannot be restricted based on their visibility or sound within the wilderness. The legislation preserves all existing water rights and interstate compacts while requiring the Secretary of Interior to secure water rights necessary to maintain stream flows and surface water levels for wilderness ecosystems, though no new water storage or diversion projects may be created within designated wilderness areas. Official maps and boundary descriptions must be filed with Congress and made publicly available within specified timeframes.

The Follow the Science Act seeks to protect the independence of research and funding decisions at the National Institutes of Health (NIH) by restricting the involvement of political appointees in agency operations. The bill prohibits political appointees—defined as high-level executive branch officials and policy-focused positions—from working at the NIH or participating in decisions about managing NIH programs, with narrow exceptions for the NIH Director and a few other top leaders. Most significantly, political appointees would be barred from reviewing, scoring, or awarding NIH grants, contracts, and other research funding. The bill also requires the NIH Director to prevent the cancellation or suspension of research agreements without written justification citing financial fraud, mismanagement, or debarment, and mandates notification to Congress within 30 days of any such actions. Within 30 days of enactment, the NIH Director must report to Congress on any political appointee participation in these activities since January 2021.

Fracturing Responsibility and Awareness of Chemicals Act of 2025This bill modifies drinking water requirements concerning hydraulic fracturing (fracking) operations, including by giving the Environmental Protection Agency (EPA) the authority to protect groundwater sources (e.g., wells) from certain pollution risks posed by fracking operations.The bill also establishes requirements for disclosing the chemicals intended for use in fracking operations as well as the chemicals actually used in the operations. If the proprietary chemical formulas of chemicals used in fracking operations are necessary for treatment in medical emergencies, then the operations must disclose the formulas or the specific chemical identities of trade secret chemicals to the state, the EPA, or the treating physicians or nurses upon request, regardless of whether written statements of need or confidentiality agreements have been provided.

Physical Therapist Workforce and Patient Access Act of 2025This bill expands certain health professional programs and Medicare covered services to include physical therapists.Specifically, the bill expands the National Health Service Corps to include physical therapists and provides for the designation of specific health professional target areas for physical therapists under the program. The bill also expands covered services of rural health clinics and federally qualified health centers under Medicare to include physical therapy services.The bill increases funds for FY2025 for the corps and requires a certain amount of funds to be used for student loan repayments for participating physical therapists in the National Health Service Corps Loan Repayment Program.

The Special Diabetes Program Reauthorization Act of 2025 extends federal funding for research and treatment programs focused on Type I diabetes. The bill allocates $160 million annually for fiscal years 2026 through 2030, with funds remaining available until spent rather than expiring at the end of each fiscal year. This legislation affects diabetes researchers, patients with Type I diabetes, and the health institutions that receive these grants to develop treatments and improve care. The bill was introduced by Representatives DeGette, Bilirakis, and Ruiz and modifies the existing Special Diabetes Programs authorization under the Public Health Service Act to ensure continued support for Type I diabetes initiatives over the next five years.

This bill provides for the relief of Jeanette Vizguerra-Ramirez.

This House resolution expresses Congress's view that the federal government has a duty to lead the world in biomedical research and calls for strengthening the National Institutes of Health (NIH). The resolution recognizes that federal funding has historically driven major medical breakthroughs—from penicillin production during World War II to recent gene therapies—and supports basic research that private industry won't fund because it's too risky or doesn't generate immediate profits. The resolution criticizes the current administration for freezing NIH grant-making, firing research staff, proposing to cut NIH funding by 40 percent, and allowing political interference in scientific decision-making. It calls for doubling federal biomedical research investment over the next decade and ensuring that research efforts focus on major health challenges including cancer, heart disease, Alzheimer's, diabetes, and rare genetic diseases while prioritizing scientific independence from political influence.

DeOndra Dixon INCLUDE Project Act of 2025This bill provides statutory authority for a program of the National Institutes of Health (NIH) that carries out research and training relating to Down syndrome, including with respect to co-occurring conditions and improving the quality of life of affected individuals. The NIH must implement the program in consultation with relevant stakeholders and avoid duplicating existing NIH Down syndrome research.Biennially, the NIH must submit to Congress a report cataloging the research, including results that may be used in medical care or clinical research.

The Protection from Cumulative Emissions and Underenforcement of Environmental Law Act of 2025 directs the Environmental Protection Agency to address environmental justice by creating a comprehensive protocol for assessing how multiple environmental stressors—including climate impacts, air and water pollution, and chemical exposure—affect public health in vulnerable communities. The EPA must develop and finalize this protocol within one year, with implementation required within three years, while also identifying at least 100 environmental justice communities that have experienced above-average environmental law violations over the past five years. For each identified community, the EPA must analyze why violations are elevated, determine root causes through resident engagement, and implement corrective measures within two years to bring violations significantly below the national average. The bill defines environmental justice communities as areas with significant populations of communities of color, low-income residents, or tribal and indigenous peoples that face disproportionate health or environmental risks.

The DOGE POUND Act restricts who can access Department of Health and Human Services (HHS) systems that contain patients' personal health information. Generally, only current HHS employees and contractors who had access before January 20, 2025, and maintained that access can continue using these systems. New individuals seeking access must meet strict requirements: holding an appropriate security clearance, having at least one year of continuous federal civil service, completing privacy and cybersecurity training, signing an ethics agreement, and meeting other conflict-of-interest standards. Anyone knowingly accessing these systems or authorizing access in violation of these rules faces criminal penalties up to 5 years in prison and fines, with a 10-year statute of limitations for prosecution. The bill also requires the HHS Inspector General to investigate and report to Congress any unauthorized access within 30 days, detailing what information was accessed and any risks posed to privacy or security.

Keep Americans Safe Act This bill establishes a new criminal offense for the import, sale, manufacture, transfer, or possession of a large capacity ammunition feeding device (LCAFD). The bill does not prohibit certain conduct with respect to an LCAFD, including the following: importation, sale, manufacture, transfer, or possession related to certain law enforcement efforts, or authorized tests or experiments; importation, sale, transfer, or possession related to securing nuclear materials; and possession by a retired law enforcement officer. The bill permits continued possession of, but prohibits sale or transfer of, a grandfathered LCAFD. Newly manufactured LCAFDs must display serial number identification and the date of manufacture. Additionally, the bill allows a state or local government to use Edward Byrne Memorial Justice Assistance Grant Program funds to compensate individuals who surrender an LCAFD under a buy-back program.

Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act or the PREVENT DIABETES ActThis bill allows health care entities to provide virtual services under the Medicare Diabetes Prevention Program for an additional three years.The Medicare Diabetes Prevention Program offers Medicare beneficiaries who are at risk of developing Type 2 diabetes specialized training and education regarding diet, exercise, and other behavioral changes. The Centers for Medicare & Medicaid Services issued temporary authorization for entities participating in the program to provide these services virtually until December 31, 2027.The bill extends the authorization for virtual services until December 31, 2030.